Article
Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse
13 Mar 2001
Abstract excerpt
Etoposide, a topoisomerase II inhibitor widely used in cancer therapy, is suspected of inducing secondary tumors and affecting the genetic constitution of germ cells. A better understanding of the potential heritable risk of etoposide is needed to provide sound genetic counseling to cancer patients treated with this drug in their reproductive years. We used a mouse model to investigate the effects of clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
